Diagnostic and (new) therapeutic options for resistant hypertension: a short review
Hypertension is a major risk factor for ischaemic heart disease and stroke. Despite the availability of numerous pharmacological treatment options, blood pressure (BP) targets are often not achieved. The inability to reach BP levels below 140/90 mmHg despite the use of three or more antihypertensive drugs is defined as resistant hypertension (RH). The etiology for RH is multifactorial. First, BP should be appropriately measured. In order to improve BP control, lifestyle modification should be recommended, adherence should be carefully assessed to exclude pseudo-resistance, and efforts should be made to exclude secondary causes of hypertension before initiating new drugs or considering device-based treatment strategies. This short review will highlight several aspects of RH management along with a focus on several new treatment options. act available.
|Keywords||Adherence, device-based therapy, hypertension, resistant hypertension|
|Journal||The Netherlands Journal of Medicine|
Feyz, L, Peeters, L.E.J, Daemen, J. (J.), & Versmissen, J. (2019). Diagnostic and (new) therapeutic options for resistant hypertension: a short review. The Netherlands Journal of Medicine, 77(10), 349–355. Retrieved from http://hdl.handle.net/1765/123408